Suppr超能文献

日本高出血风险标准的流行情况及其对急性心肌梗死患者致命性出血的预后意义。

Prevalence of the Japanese high bleeding risk criteria and its prognostic significance for fatal bleeding in patients with acute myocardial infarction.

机构信息

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Department of Genome Informatics, Osaka University Graduate School of Medicine, Osaka, Japan.

出版信息

Heart Vessels. 2021 Oct;36(10):1484-1495. doi: 10.1007/s00380-021-01836-9. Epub 2021 Mar 20.

Abstract

BACKGROUND

The Japanese high-bleeding-risk criteria (Japanese-HBR), modified criteria of the Academic Research Consortium (ARC) HBR, has been recently proposed. We aimed to investigate the prevalence of the ARC-HBR and the Japanese-HBR, and to assess their prognostic significance in patients with acute myocardial infarction (AMI).

METHODS AND RESULTS

We applied the ARC-HBR and the Japanese-HBR criteria to the OACIS prospective multicenter acute myocardial infarction registry (12,093 patients, 66 ± 12 years, 9,096 males). The primary endpoint was fatal bleeding (BARC-5). Median follow-up duration was 4.84 [inter-quartile range 1.35, 5.01] years. Prevalence of the ARC-HBR was 43.8%, while that of the Japanese-HBR was 61.8%. Cumulative incidence of fatal bleeding was higher in the ARC-HBR group than in the no ARC-HBR group at 1 year (1.3 vs. 0.6%) and at 5 years (2.0 vs. 0.7%). The Kaplan-Meier curves stratified by the Japanese-HBR criteria more prominently diverged (1.3 vs. 0.2% at 1 year; and 1.9 vs. 0.3% at 5 years). The Japanese-HBR criteria showed superior discriminative performance over the ARC-HBR criteria (C-statistics: 0.677 vs. 0.598, P < 0.001).

CONCLUSIONS

In the real-world Japanese AMI registry, nearly half of the patients fulfilled the criteria of ARC-HBR, and two-thirds met the Japanese-HBR. Our findings support the validity of both ARC- and Japanese-HBR criteria in AMI patients but encourage the future application of the Japanese-HBR criteria to the Japanese AMI cohort.

TRIAL REGISTRATION NUMBER

UMIN000004575.

摘要

背景

日本高出血风险标准(Japanese-HBR)是最近提出的,是学术研究联盟(ARC)高出血风险标准的改良标准。我们旨在研究急性心肌梗死(AMI)患者中 ARC-HBR 和 Japanese-HBR 的流行情况,并评估其预后意义。

方法和结果

我们将 ARC-HBR 和 Japanese-HBR 标准应用于 OACIS 前瞻性多中心急性心肌梗死注册研究(12093 例患者,66±12 岁,9096 例男性)。主要终点是致死性出血(BARC-5)。中位随访时间为 4.84[四分位间距 1.35,5.01]年。ARC-HBR 的患病率为 43.8%,而 Japanese-HBR 的患病率为 61.8%。在 1 年(1.3%比 0.6%)和 5 年(2.0%比 0.7%)时,ARC-HBR 组的致死性出血累积发生率高于无 ARC-HBR 组。根据 Japanese-HBR 标准分层的 Kaplan-Meier 曲线明显分开(1 年时为 1.3%比 0.2%;5 年时为 1.9%比 0.3%)。Japanese-HBR 标准比 ARC-HBR 标准具有更好的判别性能(C 统计量:0.677 比 0.598,P<0.001)。

结论

在真实世界的日本 AMI 注册研究中,近一半的患者符合 ARC-HBR 标准,三分之二的患者符合 Japanese-HBR 标准。我们的研究结果支持 ARC-HBR 和 Japanese-HBR 标准在 AMI 患者中的有效性,但鼓励未来在日本 AMI 队列中应用 Japanese-HBR 标准。

临床试验注册号

UMIN000004575。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验